Tenders/LIDOCAINE INJ (2-4 %) WITH ADRENALINE CARTIDGE OF (1.7-1.8) ML
Open🇯🇴JordanSuppliesThis tender has expired

LIDOCAINE INJ (2-4 %) WITH ADRENALINE CARTIDGE OF (1.7-1.8) ML

وزارة الصحة
Published: Jun 17, 2026
Updated: Jun 25, 2026
Source: joneps_jo

This tender has expired

The submission deadline for this tender has passed. It is no longer accepting bids.

Browse open Health & Medical tenders in Jordan

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors. Located in Jordan, Middle East & North Africa, this opportunity is open to firms and consortiums. Proposals must be submitted before June 22, 2026.

Published through JONEPS Jordan, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, originating from Jordan and sourced via joneps_jo, pertains to the procurement of Lidocaine injection solution with Adrenaline, specifically in cartridge form. This is a procurement of pharmaceutical products and medical supplies, essential for local anesthesia in various medical and dental procedures. The contracting authority, likely a healthcare provider or a government health procurement agency in Jordan, is seeking to ensure the availability of high-quality anesthetic agents. Typical requirements for such pharmaceutical tenders include strict adherence to pharmacopoeial standards (e.g., USP, EP), precise concentration specifications (2-4% Lidocaine, 1.7-1.8 ml cartridges), sterility, and appropriate packaging for safe handling and administration. Bidders are expected to provide product samples, certificates of analysis, and proof of regulatory approval for their pharmaceutical products. The tender will evaluate submissions based on product quality, compliance with international pharmaceutical manufacturing standards (GMP), expiry dates, supply chain reliability, and cost-effectiveness.

This procurement is vital for supporting clinical procedures and patient comfort in Jordan.

Data provenance

This notice is sourced from JONEPS Jordan and was originally published on June 17, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About وزارة الصحة

وزارة الصحة has issued 1,161 procurement notices on BidsFactory, including 75 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Jordan. Notices are distributed via JONEPS Jordan. Most recent publication: June 18, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Jordan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit JONEPS Jordan to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is June 22, 2026. Proposals must be received by the contracting authority before that date.

Who is the contracting authority?

This notice was issued by وزارة الصحة in Jordan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans